Active Ingredient: Imidapril
Imidapril is indicated for the treatment of essential hypertension in adults.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
5 - 20 mg
From 5 To 20 mg once every day
5 mg
Treatment should be initiated with 5 mg once a day.
If optimum control of blood pressure has not been achieved after at least 3 weeks of treatment, the daily dose should be increased to 10 mg, which has been determined to be the most effective daily dose.
However, in a small number of patients it might be necessary to increase the daily dose to 20 mg (recommended maximum dose) or preferably, to consider combination therapy with a diuretic.
It has not been assessed whether hypertensive patients would benefit from a combination of imidapril with other antihypertensive therapies.
It is recommended that the tablets be taken at about the same time of day about 15 minutes before meals, conditions under which efficacy has been demonstrated.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
